Precise Insights
Advanced Data & AI for Multiple Myeloma
On-demand access to the largest and most sophisticated oncology data for accelerated RWE and improved patient outcomes.
labs
Results from variety of patient tests
Visits
Oncology practice visits
Observations
Tumor-related observations plus vitals, biometrics, pain, and more
Procedures
Transplants, transfusions, biopsies, imaging, etc.
Medications
Start and end dates, brand vs. generic codes, dosage, duration, and cycles
Social Determinants
Social and physical environment factors
ECOG
Diagnoses
Disease state, stage, risk stratification
full ngs panel
Complete genomic report with treatment exposure and clinical outcomes
Disease Progression
Relapse and refractory
Adverse Events
Confirm the adverse event and link to treatment discontinuation
MRD
Minimal residual disease testing and results
Cost & Utilization
Adjudicated costs with linked claims data
Safety, Comorbidities
Pre-cancer and claims charge events
Specialty Pharmacy & Hub
Rx acquisition status details
Payer & Formulary
Drug tiers and coverage
Cancer Subtype
Cancer type when ICD code is unknown
Date of Initial Dx
Impute index event
Line of Therapy
Regimen or progression-based drug classes
Patient Adherence
Identify root cause of product switching
Patient Acquisition
Predict factors driving patients’ brand decision